Garcia Megias I, Almeida L, Calapaqui Teran A, Pabst K, Herrmann K, Giammarile F
Ann Nucl Med. 2025; .
PMID: 40069442
DOI: 10.1007/s12149-025-02022-x.
van Mossel S, de Feria Cardet R, de Geus-Oei L, Vriens D, Koffijberg H, Saing S
Pharmacoeconomics. 2024; 43(2):133-151.
PMID: 39488797
PMC: 11782410.
DOI: 10.1007/s40273-024-01447-y.
Baberwal P, Sonavane S, Basu S
World J Nucl Med. 2024; 23(1):54-56.
PMID: 38595842
PMC: 11001460.
DOI: 10.1055/s-0044-1779284.
Gideonse B, Birkeland M, Vilstrup M, Grupe P, Naghavi-Behzad M, Ruhlmann C
Jpn J Radiol. 2024; 42(7):753-764.
PMID: 38504000
PMC: 11217074.
DOI: 10.1007/s11604-024-01554-y.
Zamani-Siahkali N, Mirshahvalad S, Pirich C, Beheshti M
Cancers (Basel). 2024; 16(1).
PMID: 38201642
PMC: 10778455.
DOI: 10.3390/cancers16010215.
Metabolic Tumor Volume from F-FDG PET/CT in Combination with Radiologic Measurements to Predict Long-Term Survival Following Transplantation for Colorectal Liver Metastases.
Grut H, Line P, Syversveen T, Dueland S
Cancers (Basel). 2024; 16(1).
PMID: 38201449
PMC: 10777966.
DOI: 10.3390/cancers16010019.
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
Albert N, Galldiks N, Ellingson B, van den Bent M, Chang S, Cicone F
Lancet Oncol. 2024; 25(1):e29-e41.
PMID: 38181810
PMC: 11787868.
DOI: 10.1016/S1470-2045(23)00525-9.
Metabolic tumor volume predicts long-term survival after transplantation for unresectable colorectal liver metastases: 15 years of experience from the SECA study.
Grut H, Line P, Syversveen T, Dueland S
Ann Nucl Med. 2022; 36(12):1073-1081.
PMID: 36241941
PMC: 9668778.
DOI: 10.1007/s12149-022-01796-8.
The Release of a Highly Cytotoxic Paullone Bearing a TEMPO Free Radical from the HSA Hydrogel: An EPR Spectroscopic Characterization.
Veskovic A, Nakarada D, Vasiljevic O, Dobrov A, Spengler G, Enyedy E
Pharmaceutics. 2022; 14(6).
PMID: 35745747
PMC: 9227768.
DOI: 10.3390/pharmaceutics14061174.
Imaging response assessment for oncology: An algorithmic approach.
Ruchalski K, Dewan R, Sai V, McIntosh L, Braschi-Amirfarzan M
Eur J Radiol Open. 2022; 9:100426.
PMID: 35693043
PMC: 9184854.
DOI: 10.1016/j.ejro.2022.100426.
Comparison of F-NaF Imaging, Tc-MDP Scintigraphy, and F-FDG for Detecting Bone Metastases.
Dadgar H, Norouzbeigi N, Jokar N, Zareizadeh J, Gholamrezanezhad A, Ahmadzadehfar H
World J Nucl Med. 2022; 21(1):1-8.
PMID: 35502272
PMC: 9056122.
DOI: 10.1055/s-0042-1748154.
Cumulative radiation doses from recurrent PET-CT examinations.
Hosono M, Takenaka M, Monzen H, Tamura M, Kudo M, Nishimura Y
Br J Radiol. 2021; 94(1126):20210388.
PMID: 34111964
PMC: 9328066.
DOI: 10.1259/bjr.20210388.
Results of a Prospective Trial to Compare Ga-DOTA-TATE with SiPM-Based PET/CT vs. Conventional PET/CT in Patients with Neuroendocrine Tumors.
Baratto L, Toriihara A, Hatami N, Aparici C, Davidzon G, Levin C
Diagnostics (Basel). 2021; 11(6).
PMID: 34070751
PMC: 8228776.
DOI: 10.3390/diagnostics11060992.
Usefulness of semi-automatic harmonization strategy of standardized uptake values for multicenter PET studies.
Daisaki H, Kitajima K, Nakajo M, Watabe T, Ito K, Sakamoto F
Sci Rep. 2021; 11(1):8517.
PMID: 33875730
PMC: 8055685.
DOI: 10.1038/s41598-021-87942-0.
Effects of administration route on uptake kinetics of F-sodium fluoride positron emission tomography in mice.
Gonzalez-Galofre Z, Alcaide-Corral C, Tavares A
Sci Rep. 2021; 11(1):5512.
PMID: 33750874
PMC: 7970902.
DOI: 10.1038/s41598-021-85073-0.
Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy.
Wahl R, Chareonthaitawee P, Clarke B, Drzezga A, Lindenberg L, Rahmim A
J Nucl Med. 2020; 62(1):6-14.
PMID: 33334911
PMC: 9364879.
DOI: 10.2967/jnumed.120.253450.
Nuclear medicine and molecular imaging advances in the 21st century.
Vaz S, Oliveira F, Herrmann K, Veit-Haibach P
Br J Radiol. 2020; 93(1110):20200095.
PMID: 32401541
PMC: 10993229.
DOI: 10.1259/bjr.20200095.
The requirements of a specialist breast centre.
Biganzoli L, Cardoso F, Beishon M, Cameron D, Cataliotti L, Coles C
Breast. 2020; 51:65-84.
PMID: 32217457
PMC: 7375681.
DOI: 10.1016/j.breast.2020.02.003.
Performance Comparison of Individual and Ensemble CNN Models for the Classification of Brain 18F-FDG-PET Scans.
Nobashi T, Zacharias C, Ellis J, Ferri V, Koran M, Franc B
J Digit Imaging. 2019; 33(2):447-455.
PMID: 31659587
PMC: 7165199.
DOI: 10.1007/s10278-019-00289-x.
Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture.
Bailly C, Bodet-Milin C, Bourgeois M, Gouard S, Ansquer C, Barbaud M
Cancers (Basel). 2019; 11(9).
PMID: 31480470
PMC: 6770004.
DOI: 10.3390/cancers11091282.
